BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9759702)

  • 1. Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression.
    Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Miranda G; Rodríguez-Vallejo JM; González-Esteban J; Torrubia F
    Prostate; 1998 Oct; 37(2):84-90. PubMed ID: 9759702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.
    Glassman DT; Chon JK; Borkowski A; Jacobs SC; Kyprianou N
    Prostate; 2001 Jan; 46(1):45-51. PubMed ID: 11170131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.
    Wu SF; Sun HZ; Qi XD; Tu ZH
    Exp Biol Med (Maywood); 2001 Nov; 226(10):954-60. PubMed ID: 11682703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for atrophy and apoptosis in the prostates of men given finasteride.
    Rittmaster RS; Norman RW; Thomas LN; Rowden G
    J Clin Endocrinol Metab; 1996 Feb; 81(2):814-9. PubMed ID: 8636309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
    Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
    Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors.
    Laroque PA; Prahalada S; Molon-Noblot S; Cohen SM; Soper K; Duprat P; Peter CP; van Zwieten MJ
    Prostate; 1995 Sep; 27(3):121-8. PubMed ID: 7567690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrillar collagen genes are not coordinately upregulated with TGF β1 expression in finasteride-treated prostate.
    Delella FK; de Almeida FLA; Nunes HC; Rinaldi JC; Felisbino SL
    Cell Biol Int; 2017 Nov; 41(11):1214-1222. PubMed ID: 28493523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia.
    Bozec A; Ruffion A; Decaussin M; Andre J; Devonec M; Benahmed M; Mauduit C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):17-25. PubMed ID: 15507514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative evaluation of prostatic histomorphology in rats following chronic treatment with finasteride, a 5-alpha reductase inhibitor.
    Prahalada SR; Keenan KP; Hertzog PR; Gordon LR; Peter CP; Soper KA; van Zwieten MJ; Bokelman DL
    Urology; 1994 May; 43(5):680-5. PubMed ID: 7513109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
    Hsieh JT; Chen SC; Yu HJ; Chang HC
    Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia.
    Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA
    J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.
    Sutton MT; Yingling M; Vyas A; Atiemo H; Borkowski A; Jacobs SC; Kyprianou N
    Prostate; 2006 Aug; 66(11):1194-202. PubMed ID: 16652387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.
    Bauman TM; Sehgal PD; Johnson KA; Pier T; Bruskewitz RC; Ricke WA; Huang W
    Prostate; 2014 Jun; 74(9):923-32. PubMed ID: 24789081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
    Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
    Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.